Terms: = Liver cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1
17 results:
1. Ultrasensitive and Quantitative DNA Methylation Detection Method Based on the MutS Protein.
Zhang L; Zhang W; Mu Y; Hu H; Dong K; Wen X; Ye Z; Sun Q; Yan B; Mao Z; Xiao X
Anal Chem; 2023 Dec; 95(51):18828-18835. PubMed ID: 38078896
[TBL] [Abstract] [Full Text] [Related]
2. Methylated sept9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population.
Zheng K; Dai L; Zhao Y; Li L; Li W; Zhang X; Su Q; Wu R; Jiang Y; Chen Y; Ran J
BMC Gastroenterol; 2023 Jul; 23(1):260. PubMed ID: 37525116
[TBL] [Abstract] [Full Text] [Related]
3. Methylated sept9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.
Saeki I; Suehiro Y; Yamauchi Y; Hoshida T; Tanabe N; Oono T; Kawamoto D; Nishimura T; Matsumoto T; Ishikawa T; Shimokawa M; Tamori A; Kawada N; Tamai Y; Iwasa M; Nakagawa H; Nagano H; Takami T; Yamasaki T
Hepatol Int; 2023 Oct; 17(5):1289-1299. PubMed ID: 37186217
[TBL] [Abstract] [Full Text] [Related]
4. [Expression and clinical significance of plasma methylated SEPT 9 gene in patients with primary liver cancer].
He N; Feng G; Zhang FN; Hao S; Li R; Zhao ZQ; Tian YW; Yan HL
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):265-270. PubMed ID: 37137852
[No Abstract] [Full Text] [Related]
5. sept9 Expression in Hepatic Nodules: An Immunohistochemical Study of Hepatocellular Neoplasm and Metastasis.
Kmeid M; Park YN; Chung T; Pacheco RR; Arslan ME; Lee H
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):278-287. PubMed ID: 36867734
[TBL] [Abstract] [Full Text] [Related]
6. Role of Plasma methylated sept9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma.
Huang F; Yang G; Jiang H; Chen X; Yang Y; Yu Q; Pan B; Wang B; Guo W; Yang W; Zhang C
Technol Cancer Res Treat; 2022; 21():15330338221144510. PubMed ID: 36573042
[No Abstract] [Full Text] [Related]
7. msept9 Can Monitor the Response and Predict the Prognosis of Stage IV Colorectal cancer Patients with liver Metastasis Undergoing Potentially Curative Surgery.
Liu W; Hu P; Liu J; Chen L
J Surg Res; 2021 Nov; 267():485-494. PubMed ID: 34246842
[TBL] [Abstract] [Full Text] [Related]
8. PA-ResSeg: A phase attention residual network for liver tumor segmentation from multiphase CT images.
Xu Y; Cai M; Lin L; Zhang Y; Hu H; Peng Z; Zhang Q; Chen Q; Mao X; Iwamoto Y; Han XH; Chen YW; Tong R
Med Phys; 2021 Jul; 48(7):3752-3766. PubMed ID: 33950526
[TBL] [Abstract] [Full Text] [Related]
9.
Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
[TBL] [Abstract] [Full Text] [Related]
10. liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes.
Vidal-Vanaclocha F; Crende O; García de Durango C; Herreros-Pomares A; López-Doménech S; González Á; Ruiz-Casares E; Vilboux T; Caruso R; Durán H; Gil A; Ielpo B; Lapuente F; Quijano Y; Vicente E; Vidal-Lartitegui L; Sotomayor EM
Semin Cancer Biol; 2021 Jun; 71():122-133. PubMed ID: 32805395
[TBL] [Abstract] [Full Text] [Related]
11. Detection of Colorectal cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing.
Li J; Zhou X; Liu X; Ren J; Wang J; Wang W; Zheng Y; Shi X; Sun T; Li Z; Kang A; Tang F; Wen L; Fu W
Clin Chem; 2019 Jul; 65(7):916-926. PubMed ID: 31010820
[TBL] [Abstract] [Full Text] [Related]
12. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal cancer liver Metastasis.
Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
[TBL] [Abstract] [Full Text] [Related]
13. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
[TBL] [Abstract] [Full Text] [Related]
14. Plasma msept9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of a sept9 interacting protein, SEPT14, a novel testis-specific septin.
Peterson EA; Kalikin LM; Steels JD; Estey MP; Trimble WS; Petty EM
Mamm Genome; 2007 Nov; 18(11):796-807. PubMed ID: 17922164
[TBL] [Abstract] [Full Text] [Related]
16. Multimodality expression profiling shows sept9 to be overexpressed in a wide range of human tumours.
Scott M; Hyland PL; McGregor G; Hillan KJ; Russell SE; Hall PA
Oncogene; 2005 Jul; 24(29):4688-700. PubMed ID: 15782116
[TBL] [Abstract] [Full Text] [Related]
17. SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24.
Ono R; Taki T; Taketani T; Kawaguchi H; Taniwaki M; Okamura T; Kawa K; Hanada R; Kobayashi M; Hayashi Y
Cancer Res; 2002 Jan; 62(2):333-7. PubMed ID: 11809673
[TBL] [Abstract] [Full Text] [Related]
